Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine charlotteobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from charlotteobserver.com Daily Mail and Mail on Sunday newspapers.
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.
Moderna announces Phase 3 trial results for mRNA-1283, its next-gen COVID-19 vaccine. A higher immune response was observed compared to mRNA-1273.222. Detailed data will be unveiled at upcoming events.